Microbio Co Ltd Market Cap ($255.72 Million)
Market Cap & Net Worth: Microbio Co Ltd (4128)
Microbio Co Ltd market cap. Microbio Co Ltd (TWO:4128) has a market capitalization of $255.72 Million (NT$8.12 Billion) as of November 5, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #15346 globally and #674 in its home market, demonstrating a -5.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Microbio Co Ltd's stock price NT$13.80 by its total outstanding shares 588170597 (588.17 Million). Also see Microbio Co Ltd (4128) cash conversion ratio for how efficiently the company converts equity into cash flow.
Microbio Co Ltd Market Cap History (2015–2026)
Microbio Co Ltd market cap history from 2015 to 2026. Data shows change from $353.29 Million to $255.72 Million (-3.03% CAGR). Check 4128 share price today for real-time trading data and today's change.
Microbio Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Microbio Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Microbio Co Ltd to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.18x
Microbio Co Ltd's market cap is 0.18 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $307.30 Million | $1.52 Billion | -$267.81 Million | 0.20x | N/A |
| 2017 | $295.97 Million | $1.41 Billion | $543.03 Million | 0.21x | 0.55x |
| 2018 | $167.98 Million | $1.45 Billion | -$690.74 Million | 0.12x | N/A |
| 2019 | $189.31 Million | $1.47 Billion | -$264.60 Million | 0.13x | N/A |
| 2020 | $906.56 Million | $1.60 Billion | $519.84 Million | 0.57x | 1.74x |
| 2021 | $1.01 Billion | $1.78 Billion | -$233.16 Million | 0.57x | N/A |
| 2022 | $998.89 Million | $1.72 Billion | $152.42 Million | 0.58x | 6.55x |
| 2023 | $891.23 Million | $1.59 Billion | -$1.18 Billion | 0.56x | N/A |
| 2024 | $611.51 Million | $1.72 Billion | -$1.10 Billion | 0.35x | N/A |
| 2025 | $342.82 Million | $1.89 Billion | -$757.75 Million | 0.18x | N/A |
Competitor Companies of 4128 by Market Capitalization
Companies near Microbio Co Ltd in the global market cap rankings as of November 5, 2026. Also see balance sheet size of Microbio Co Ltd for a full breakdown of the balance sheet.
Key companies related to Microbio Co Ltd by market ranking:
- Nestlé S.A (F:NESM): Ranked #87 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #102 globally with a market cap of $199.45 Billion USD ( CHF157.76 Billion CHF).
- Danone SA (PA:BN): Ranked #535 globally with a market cap of $50.93 Billion USD ( €43.56 Billion EUR).
- Danone SA (F:BSND): Ranked #674 globally with a market cap of $39.61 Billion USD ( €33.88 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Nestlé S.A | F:NESM | $224.33 Billion | €92.00 |
| #102 | Nestle S.A. | SW:NESN | $199.45 Billion | CHF84.41 |
| #535 | Danone SA | PA:BN | $50.93 Billion | €67.64 |
| #674 | Danone SA | F:BSND | $39.61 Billion | €13.30 |
Market Capitalization of Microbio Co Ltd (2015–2026)
Market capitalization of Microbio Co Ltd from 2015 to today. Between 2015 and today, Microbio Co Ltd's market cap moved from $353.29 Million to $ 255.72 Million, with a yearly change of -3.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$255.72 Million | -25.41% |
| 2025 | NT$342.82 Million | -43.94% |
| 2024 | NT$611.51 Million | -31.39% |
| 2023 | NT$891.23 Million | -10.78% |
| 2022 | NT$998.89 Million | -1.55% |
| 2021 | NT$1.01 Billion | +11.92% |
| 2020 | NT$906.56 Million | +378.87% |
| 2019 | NT$189.31 Million | +12.70% |
| 2018 | NT$167.98 Million | -43.24% |
| 2017 | NT$295.97 Million | -3.69% |
| 2016 | NT$307.30 Million | -13.02% |
| 2015 | NT$353.29 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Microbio Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $255.72 Million USD |
| MoneyControl | $255.72 Million USD |
| MarketWatch | $255.72 Million USD |
| marketcap.company | $255.72 Million USD |
| Reuters | $255.72 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Microbio Co Ltd
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and health foods in Taiwan. It provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. The company is also involved in the sale of organic food and beverages; provision of te… Read more